Page 71 - 2025中醫藥與天然藥物聯合學術研討會-中醫藥與天然藥物的挑戰Ｘ機遇與未來大會手冊

陳儀莊 特聘研究員 Yi-juang Chern, PhD

◼ Position/Affiliation/E-mail
Position/Affiliation:

Distinguished Research Fellow and Director, Institute of Biomedical
Sciences Academia Sinica.
E-mail: skin@mail.fju.edu.tw

◼ Biography
Dr. Yijuang Chern received her Ph.D. in Molecular and Cellular Biology from the University
of Massachusetts Amherst (USA) and completed her postdoctoral training in Signal
Transduction at Harvard Medical School (USA). She has served as Deputy Minister at the

National Science and Technology Council and is currently a Distinguished Research Fellow
and Director of the Institute of Biomedical Sciences at Academia Sinica (Taiwan). Her
laboratory focuses on two interrelated research areas: (1) the functional characterization of the
A2A adenosine receptor (A2AR) and (2) the development of novel therapeutic strategies for

neurodegenerative diseases, including Huntington’s disease, amyotrophic lateral sclerosis, and
Alzheimer’s disease. Her goal is to develop biomarkers and treatments for neurodegenerative
diseases based on the functional and pharmacological properties of A2AR and novel mechanisms
of disease pathogenesis. Her studies on A2AR and degenerative diseases have resulted in 27

patents and several additional patent applications. In addition, Dr. Chern has published 136
papers and five book chapters and has an h-index of 53 (as of August 14, 2025).

49